Metronidazol Baxter Viaflo Innrennslislyf, lausn 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metronidazol baxter viaflo innrennslislyf, lausn 5 mg/ml

baxter medical ab - metronidazolum inn - innrennslislyf, lausn - 5 mg/ml

Metronidazol Normon Innrennslislyf, lausn 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metronidazol normon innrennslislyf, lausn 5 mg/ml

laboratorios normon, s.a. - metronidazolum inn - innrennslislyf, lausn - 5 mg/ml

Enhertu Evrópusambandið - íslenska - EMA (European Medicines Agency)

enhertu

daiichi sankyo europe gmbh - trastuzumab deruxtecan - brjóstakrabbamein - Æxlishemjandi lyf - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Dovprela (previously Pretomanid FGK) Evrópusambandið - íslenska - EMA (European Medicines Agency)

dovprela (previously pretomanid fgk)

mylan ire healthcare limited - pretomanid - berklar, fjölþol-þolir - antimycobacterials - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Pentavac Stungulyfsstofn og dreifa, dreifa Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pentavac stungulyfsstofn og dreifa, dreifa

sanofi pasteur* - filamentous haemagglutinin; poliovirus inactivated type 2; poliovirus inactivated type 3; diphtheria toxoid; tetanus toxoid; poliovirus inactivated type 1; pertussis toxoid; haemophilus influenzae type b - stungulyfsstofn og dreifa, dreifa